Try our beta test site

Bevacizumab vs Dacarbazine in Metastatic Melanoma

This study has been terminated.
(Lack of financing of the study drug. Not sufficient financial support.)
Sponsor:
Collaborators:
The Norwegian Melanoma Group
Norwegian Cancer Society
Information provided by (Responsible Party):
Haukeland University Hospital
ClinicalTrials.gov Identifier:
NCT01705392
First received: October 8, 2012
Last updated: February 23, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 20, 2017
  Primary Completion Date: February 20, 2017 (Final data collection date for primary outcome measure)